STAAR Surgical | STAA - Selling And Administration Expenses

Stock Price
18.02
Daily Change
0.26 1.46%
Monthly
-5.70%
Yearly
11.10%
Q1 Forecast
17.21

STAAR Surgical reported $59.38M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.13B 125M Dec/2025
Bausch Health Companies USD 801M 6M Dec/2025
Boston Scientific USD 1.83B 93M Dec/2025
Cerus USD 19.33M 1.55M Dec/2024
Cooper Companies USD 419.2M 12M Sep/2025
Exact Sciences USD 491.64M 35.94M Sep/2025
Hologic USD 2.5B 2.24B Dec/2025
J&J USD 6.75B 831M Dec/2025
Merit Medical Systems USD 107.38M 5.72M Sep/2025
Novartis USD 3.31B 134M Sep/2025
OraSure Technologies USD -0.06 0.05 Sep/2024
Orthofix International USD 112.21M 1.1M Sep/2024
Rockwell Medical USD 4.04M 330K Jun/2024
STAAR Surgical USD 59.38M 18.08M Sep/2025
Utah Medical Products USD 1.87M 50K Sep/2024